| NCT Number | NCT07116759 |
| Lead Sponsor | Abramson Cancer Center at Penn Medicine
Collaborators: National Cancer Institute (NCI) |
| Conditions | Healthy |
| Enrollment | 20 participants |
| Start Date | 2022-10-09 |
| Primary Completion | 2024-10-01 (estimated) |
| Study Completion | 2025-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-09 |